financetom
Business
financetom
/
Business
/
Nurix Therapeutics Insider Sold Shares Worth $400,216, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nurix Therapeutics Insider Sold Shares Worth $400,216, According to a Recent SEC Filing
Jun 20, 2024 2:29 PM

05:03 PM EDT, 06/20/2024 (MT Newswires) -- Hans van Houte, Chief Financial Officer, on June 20, 2024, sold 20,000 shares in Nurix Therapeutics ( NRIX ) for $400,216. Following the Form 4 filing with the SEC, Van Houte has control over a total of 48,333 shares of the company, with 48,333 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1549595/000154959524000088/xslF345X03/wk-form4_1718917093.xml

Price: 20.30, Change: -0.67, Percent Change: -3.20

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved